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Abstract
Background: Studies have shown that the barks and roots of some Apocynaceae species have anticancer and
antimalarial properties. In this study, leaf extracts of five selected species of Apocynaceae used in traditional
medicine (Alstonia angustiloba, Calotropis gigantea, Dyera costulata, Kopsia fruticosa and Vallaris glabra) were
assessed for antiproliferative (APF) and antiplasmodial (APM) activities, and analysed for total alkaloid content (TAC),
total phenolic content (TPC) and radical-scavenging activity (RSA). As V. glabra leaf extracts showed wide spectrum
APF and APM activities, they were further screened for saponins, tannins, cardenolides and terpenoids.
Methods: APF and APM activities were assessed using the sulphorhodamine B and lactate dehydrogenase assays,
respectively. TAC, TPC and RSA were analysed using Dragendorff precipitation, Folin-Ciocalteu and DPPH assays,
respectively. Screening for saponins, tannins, cardenolides and terpenoids were conducted using the frothing, ferric
chloride, Kedde and vanillin-H2SO4 tests, respectively.
Results: Leaf extracts of A. angustiloba, C. gigantea and V. glabra displayed positive APF activity. Dichloromethane
(DCM) extract of C. gigantea, and DCM and DCM:MeOH extracts of V. glabra showed strong APF activity against all
six human cancer cell lines tested. DCM extract of A. angustiloba was effective against three cancer cell lines.
Against MCF-7 and MDA-MB-231 cell lines, DCM extract of C. gigantea was stronger than standard drugs of
xanthorrhizol, curcumin and tamoxifen. All five species were effective against K1 strain of Plasmodium falciparum
and three species (C. gigantea, D. costulata and K. fruticosa) were effective against 3D7 strain. Against K1 strain, all
four extracts of V. glabra displayed effective APM activity. Extracts of D. costulata were effective against 3D7 strain.
Selectivity index values of extracts of A. angustiloba, C. gigantea and V. glabra suggested that they are potentially
safe for use to treat malaria. Extracts of K. fruticosa had the highest TAC while D. costulata had the highest TPC and
RSA. Phytochemical screening of extracts of V. glabra also showed the presence of terpenoids, tannins and
saponins.
Conclusions: Leaf extracts of C. gigantea and V. glabra showed great promise as potential candidates for
anticancer drugs as they inhibited the growth of all six cancer cell lines. Against K1 strain of P. falciparum, all four
extracts of V. glabra displayed effective APM activity. The wide spectrum APF and APM activities of V. glabra are
reported for the first time and this warrants further investigation into its bioactive compounds.
Background
The family Apocynaceae consists of about 250 genera
and 2000 species of tropical trees, shrubs and vines [1,2].
A characteristic feature of the family is that almost all
species produce milky sap. Leaves are simple, opposite
and whorled. Flowers are large and colourful.
In traditional medicine, Apocynaceae species are used
to treat gastrointestinal ailments, fever, malaria, pain
and diabetes [2]. Of the five species studied, roots and
leaves of Calotropis gigantea (L.) Aiton are used to treat
skin and liver diseases, leprosy, dysentery, worms, ulcers,
tumours and earaches [3]. Its latex has been reported to
have wound healing properties [4]. Kopsia fruticosa
(Ker.) A. DC. is used to treat sore and syphilis, and has
cholinergic effects [5]. Leaves and barks of Dyera costu-
lata Hook have been used for treating fever, inflamma-
tion and pain [6]. Stems, leaves and latex of Alstonia
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blems and skin sores in Indonesia [7]. Leaves are exter-
nally applied to treat headache in Malaysia [8]. Vallaris
glabra Kuntze is well known in Thailand because the
scent of its flowers is similar to that of pandan leaves
and aromatic rice [9]. Its use in traditional medicine has
not been reported, and its bioactivity and phytochemis-
try have yet to be studied. Species of Apocynaceae have
also been reported to possess anticancer properties
[2,10]. Species having cytotoxic activity include those of
Allamanda [11], Alstonia [12,13], Cerbera [14,15], Ner-
ium [16,17], Plumeria [18] and Tabernaemontana [19].
Species of Apocynaceae, notably those of Alstonia,a r e
also known to have antimalarial properties [20-22].
Prompted by the anticancer and antimalarial proper-
ties of Apocynaceae, leaf extracts of five selected species
used in traditional medicine were assessed for antiproli-
ferative (APF) activity against six human cancer cell
lines and for antiplasmodial (APM) activity against two
strains of Plasmodium falciparum.T h e i re x t r a c t sw e r e
also analysed for total alkaloid content, total phenolic
content and radical-scavenging activity. Having wide
spectrum APF and APM activities, leaf extracts of V.
glabra were further screened for saponins, tannins, car-
denolides and terpenoids. Information from the screen-
ing will serve as a useful guide to further work on
isolating compounds with APF and APM activities.
Methods
Plant materials
Species studied were A. angustiloba, C. gigantea, D. cos-
tulata, K. fruticosa and V. glabra. Leaf samples of A.
angustiloba, C. gigantea and V. glabra were collected
from Puchong (3°2’42"N; 101°37’12"E), Sunway
(3°4’30"N; 101°36’8” E) and Kepong (3°12’14"N;
101°37’50"E) in Selangor, Malaysia, respectively. Those
of D. costulata and K. fruticosa were collected from
the Forest Research Institute Malaysia (3°14’6"N;
101°37’58"E). Identification of species was based on
documented descriptions and illustrations [1,2]. With
brief descriptions of their morphology and location of
collection, the voucher specimens of these species
(WSK01, WSK02, WSK03, WSK04 and WSK05, respec-
tively) were deposited in the herbarium of Monash Uni-
versity Sunway Campus in Malaysia.
Extraction of leaves
For crude extraction, fresh leaves of each species (40 g)
were cut into small pieces and freeze-dried overnight.
Dried samples were blended and extracted with 250 ml
of methanol (MeOH) three times for 1 h each time.
Samples were filtered and the solvent was removed
using a rotary evaporator (Eyela). The dried crude
extracts were stored at -20°C for further analysis. For
sequential extraction, fresh leaves of each species (40 g)
were freeze-dried, ground and extracted successively
with hexane (HEX), dichloromethane (DCM), DCM:
MeOH (1:1) and MeOH (HmbG Chemicals). For each
solvent, the suspension of ground leaves in 250-300 ml
of solvent was shaken for 1 h on the orbital shaker.
After filtering, the samples were extracted two more
times for each solvent. Solvents were removed with a
rotary evaporator to obtain the dried extracts, which
were stored at -20°C for further analysis.
Antiproliferative activity
Antiproliferative (APF) activity of extracts (25 μg/ml)
was initially screened for growth inhibitory activity
against three human cancer cell lines (MCF-7, MDA-
MB-231 and HeLa) using the sulphorhodamine B (SRB)
assay [23]. Growth inhibitory activity with less than 50%
cell growth was considered positive while that with
more than 50% cell growth was considered negative.
Extracts with positive growth inhibition were further
tested against six human cancer lines (MCF-7, MDA-
MB-231, HeLa, HT-29, SKOV-3 and HepG2) using six
different extract concentrations. Human cancer cell lines
were obtained from the American Type Culture Collec-
tion (ATCC, Manassas, VA, USA). The cells were
seeded 24 h prior to treatment in 96-well plates at den-
sities of 10,000-20,000 cells/well. Each cell line was
designated one plate. Initial cell population of each cell
lines prior to addition of extracts was determined by fix-
ing with trichloroacetic acid (TCA) (Sigma). Extracts
were dissolved in dimethyl sulphoxide (DMSO) (Sigma)
and serially diluted from 8-25 μg/ml. Control cultures
were treated with the same volume of DMSO. The con-
centration of DMSO was kept within 1% to avoid any
interference with cell viability. After the addition of
extracts, the plates were incubated for 48 h. After incu-
bation, the cells were fixed with 50 μl of cold 50% TCA
and incubated for 1 h at 4°C. The plates were then
washed with tap water and air dried. Cells were stained
with 100 μl of 0.4% SRB solution (Sigma) diluted with
1% acetic acid followed by incubation for 10 min at
room temperature. Unbound dye was removed by wash-
ing with 1% acetic acid. Bound stain was then solubi-
lised with 200 μlo f1 0m Mt r i z m ab a s e( S i g m a ) .
Absorbance of each well at 505 nm was obtained using
am i c r o p l a t er e a d e r .D o s e - r e s p o n s ec u r v e sw e r ec o n -
structed to obtain GI50 or concentration of extract that
causes growth inhibition (GI) of cells by 50%. GI50 was
calculated using the formula [(Tz -T i)/(Tc -T i)] ×
100 = 50 where Tz is the absorbance of cells treated
with extracts or drugs at the end of incubation, Ti is the
absorbance of cells prior to treatment with extracts or
drugs and Tc is the absorbance of untreated cells at the
end of incubation [24]. IC50 or inhibition concentration
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using the formula Tz/Tc × 100 = 50. Activity is consid-
ered to be effective when GI50 value ≤20 μg/ml [25].
Antiplasmodial activity
Antiplasmodial (APM) activity of extracts was assessed
in vitro in human blood using the lactate dehydrogenase
assay with slight modifications [26]. Chloroquine-
resistant K1 and chloroquine-sensitive 3D7 strains of
Plasmodium falciparum were tested. Standard drugs of
artemisinin (Sigma) and mefloquine (Sigma) were used
as positive controls. Extracts dissolved in DMSO
(10 mg/ml) were diluted with deionised water to 320
μg/ml. The solution was serially diluted two-fold six
times to give seven different concentrations. Aliquots of
each concentration (10 μl) were transferred into 96-well
microtiter plates. Parasitised red blood cell suspensions
(1% parasitaemia, 190 μl) were added to each well. Para-
sitised and non-parasitised red blood cells were used as
negative controls. The plates were incubated for 24 h at
37°C in a candle jar and were subsequently chilled at
-20°C to lyse the red blood cells. The plates were then
a l l o w e dt oc o o lt or o o mt e m p e r a t u r e ,a n d2 0μlo f
blood suspension was dispensed into a new microtiter
plate containing 100 μl MALSTAT™ reagent (Flow
Inc.), and 20 μl of nitroblue tetrazolium (Sigma) and
phenazine ethosulphate (Sigma) mixture. Absorbance
was measured with a plate reader at 630 nm. Percentage
inhibition at each concentration was determined and the
mean of EC50 values of parasite viability was calculated
using probit analysis. EC50 or effective concentration is
the extract concentration that kills 50% of malaria
parasites. Activity is effective if EC50 value ≤10 μg/ml
[27]. The selectivity index (SI) for APM activity was
calculated based on the ratio of cytotoxicity (IC50)o n
HepG2 and MCF-7 cells to APM activity (EC50)o n
chloroquine-resistant K1 strain.
Analysis of TAC, TPC and RSA
Total alkaloid content
Total alkaloid content (TAC) of extracts was determined
using the Dragendorff precipitation assay [28]. For each
species, extracts (15 mg) were dissolved in 1 ml of dis-
tilled water that was acidified to pH 2.0-2.5 with 0.01 M
HCl. Analysis was conducted in triplicate. Alkaloids
were then precipitated with 0.4 ml of Dragendorff
reagent. After washing with 0.5 ml of distilled water to
remove traces of the reagent, the precipitate was later
treated with 0.4 ml of 1% sodium sulphide, resulting in
a brownish-black precipitate. Precipitates formed at each
stage were recovered by centrifugation at 14,000 rpm
for 1 min. The resulting precipitate was dissolved in
0.2 ml of concentrated nitric acid and diluted to 1 ml
with distilled water. Addition of 2.5 ml of 3% thiourea
to 0.5 ml aliquots of this solution resulted in a yellow
colored complex. Absorbance was measured at 435 nm
and TAC was expressed as boldine equivalent in milli-
gram per gram of extract. The calibration equation for
boldine (Sigma) was y = 1.068x (R
2 = 0.9959) where y is
absorbance and × is mg/ml of boldine. Dragendorff
reagent was prepared by dissolving 0.8 g of bismuth
nitrate (Sigma) in 40 ml of distilled water and 10 ml of
glacial acetic acid. The resulting solution was mixed
with 20 ml of 40% potassium iodide.
Total phenolic content
Total phenolic content (TPC) of extracts was deter-
mined using the Folin-Ciocalteu (FC) assay [29-31].
Extracts (300 μl in triplicate) were introduced into test
tubes followed by 1.5 ml of FC reagent (Fluka) at
10 times dilution and 1.2 ml of sodium carbonate (Fluka)
at 7.5% w/v. The tubes were allowed to stand for 30 min
in the dark before absorbance was measured at 765 nm.
TPC was expressed as gallic acid (GA) equivalent in
milligram per gram of extract. The calibration equation
for GA (Fluka) was y = 0.0111x - 0.0148 (R
2 = 0.9998)
where y is absorbance and × is mg/ml of GA.
Radical-scavenging activity
Radical-scavenging activity (RSA) of extracts was deter-
mined using the 1,1-diphenyl-2-picrylhydrazyl (DPPH)
assay [29-31]. Different dilutions of extracts (1 ml in tri-
plicate) were added to 2 ml of DPPH (Sigma). The con-
centration of DPPH used was 5.9 mg in 100 ml of
methanol. Absorbance was measured at 517 nm after
30 min. RSA was calculated as IC50, the concentration
of extract to scavenge 50% of the DPPH radical. RSA
w a st h e ne x p r e s s e da sa s c o r b i ca c i de q u i v a l e n ta n t i o x i -
dant capacity (AEAC) using the equation: AEAC (mg
ascorbic acid/g) = IC50(ascorbate)/IC50(sample) ×1 0
5.I C 50 of
ascorbic acid used for calculation of AEAC was 0.00387
mg/ml.
Phytochemical screening
Qualitative phytochemical screening for saponins, tan-
nins, cardenolides and terpenoids from leaf extracts of
V. glabra was carried out using standard phytochemical
procedures [32,33]. The frothing test was used for sapo-
nins, the ferric chloride test for tannins, the Kedde test
for cardenolides and the vanillin-H2SO4 test for
terpenoids.
Results and Discussion
APF activity
Initial screening of leaf extracts of five Apocynaceae spe-
cies against three human cancer cell lines (MCF-7,
MDA-MB-231 and HeLa) showed that DCM, DCM:
MeOH and MeOH extracts of A. angustiloba, C. gigan-
tea and V. glabra had growth inhibitory activity
(data not shown). DCM and DCM:MeOH extracts of
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three cancer cell lines. HEX and MeOH extracts of all
three species did not show inhibition, with the exception
of MeOH extract of V. glabra. Extracts of D. costulata
and K. fruticosa did not show any APF activity.
Extracts of the three species were further tested against
six human cancer cell lines (MCF-7, MDA-MB-231,
HeLa, HT-29, SKOV-3 and HepG2). Results showed that
DCM extract of A. angustiloba inhibited only MDA-MB-
231, HeLa and SKOV-3 cell lines with GI50 values of 20,
20 and 16 μg/ml, respectively (Table 1). DCM and DCM:
MeOH extracts of C. gigantea inhibited all cancer cell
lines except for DCM:MEOH extract against MDA-MB-
231. APF activity of DCM extract of C. gigantea was the
strongest with GI50 values ranging from 1.3 to 3.3 μg/ml.
Against MCF-7 and MDA-MB-231, GI50 of DCM extract
of C. gigantea (1.9 and 1.3 μg/ml) was stronger than that
of xanthorrhizol (11 and 8.7 μg/ml), curcumin (4.1 and
8.7 μg/ml) and tamoxifen (8.3 and 4.6 μg/ml), respec-
tively. DCM and DCM:MeOH extracts of V. glabra
inhibited all cell lines with GI50 values ranging from 7.5-
12 μg/ml and 5.8-13 μg/ml, respectively. In addition,
MeOH extract of V. glabra also inhibited the growth of
MCF-7 and HepG2. Against MCF-7, GI50 of DCM and
DCM:MeOH extracts of V. glabra (7.7 and 7.0 μg/ml)
was stronger than xanthorrhizol (11 μg/ml) and compar-
able to tamoxifen (8.3 μg/ml), respectively.
To the best of our knowledge, this study represents
the first report of cytotoxic activity from DCM leaf
extract of A. angustiloba and DCM and DCM:MeOH
extracts of V. glabra. Earlier studies have reported cyto-
toxic activity from the root bark of Alstonia macro-
phylla Wall. ex G. Don [12] and the stem bark of
Alstonia scholaris R. Br. [13]. A recent study on Vallaris
solanacea (Roth) Kuntz has reported potent cell growth
inhibitory activity of cardenolide glycosides isolated
from the plant [34]. The finding of strong APF activity
from DCM and DCM:MeOH extracts of C. gigantea
from this study is supported by an earlier report that
DCM leaf extracts of C. gigantea had strong inhibitory
activity against KB, BC and NCI-H187 cancer cell lines
[35]. Ethanol root extracts of C. gigantea were also
reported to be cytotoxic to K562 and SGC-7901 human
cell lines [36].
APM activity
Against chloroquine-resistant K1 strain of P. falciparum,
leaves of V. glabra were most effective as all four
extracts had APM activity with EC50 less than 10 μg/ml
(Table 2). DCM extract was the strongest with EC50 of
0.85 μg/ml. Three extracts of A. angustiloba,a n dt w o
extracts of C. gigantea, D. costulata and K. fruticosa
showed APM activity. It should be noted that DCM:
MeOH extracts of all five species displayed APM activity
with A. angustiloba having the strongest activity (EC50
of 0.46 μg/ml).
Against chloroquine-sensitive 3D7 strain of P. falci-
parum,e x t r a c t so fA. angustiloba and V. glabra showed
Table 1 Antiproliferative activity of leaf extracts of three Apocynaceae species against six human cancer cell lines
a
Species
cLeaf extract
bGI50 (μg/ml)
MCF-7 MDA-MB-231 HeLa HT-29 SKOV-3 HepG2
Alstonia angustiloba HEX - - - - - -
DCM - 20 ± 1.7 20 ± 1.1 - 16 ± 1.4 -
DCM:MeOH - - - - - -
MeOH - - - - - -
Calotropis gigantea HEX - - - - - -
DCM 1.9 ± 0.2 1.3 ± 0.3 2.5 ± 0.5 3.3 ± 0.2 2.5 ± 0.2 1.8 ± 1.7
DCM:MeOH 13 ± 0.3 - 15 ± 1.0 24 ± 0.7 20 ± 2.3 16 ± 3.5
MeOH - - - - - -
Vallaris glabra HEX - - - - - -
DCM 7.7 ± 1.3 12 ± 2.0 9.8 ± 1.5 9.3 ± 2.0 7.5 ± 4.5 7.6 ± 0.2
DCM:MeOH 7.0 ± 2.5 13 ± 6.3 8.5 ± 2.9 12 ± 1.2 7.7 ± 2.4 5.8 ± 1.2
MeOH 16 ± 2.1 - - - - 19 ± 0.9
dStandard drug
Xanthorrhizol 11 ± 0.7 8.7 ± 0.8
Curcumin 4.1 ± 0.9 8.7 ± 0.8
Tamoxifen 8.3 ± 0.6 4.6 ± 0.5
a Initial screening showed that extracts of Dyera costulata and Kopsia fruticosa did not show any APF activity.
b GI50 (μg/ml) is growth inhibition (GI) of cancer cell lines by 50%. Inhibition is not effective (-) with values >20 μg/ml. MCF-7 and MDA-MB-231, HeLa and SKOV-
3, HT-29, and HepG2 are human breast, cervical, colon and liver cancer cell lines, respectively.
c HEX, hexane; DCM, dichloromethane; MeOH, methanol.
d Data on standard drugs of xanthorrhizol, curcumin and tamoxifen against MCF-7 and MDA-MD-231 cell lines are from an earlier publication [24].
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in that DCM, DCM:MeOH and MeOH extracts showed
positive APM activity with EC50 of 8.31, 2.13 and 3.56
μg/ml, respectively. Generally, extracts were less effec-
tive against 3D7 strain.
This finding complements an earlier report that alka-
loids from the extracts of Alstonia species were effective
against chloroquine-resistant K1 strain but not against
chloroquine-sensitive T9-96 strain [22]. Previous studies
on the APM activity of Apocynaceae were focused on
Alstonia species [21,22]. This study is the first to report
the APM activity of leaf extracts of D. costulata, C.
gigantea, K. fruticosa and V. glabra. A notable finding is
the APM activity of V. glabra against K1 strain in all
solvent fractions.
Selectivity index
The selectivity index (SI) for APM activity indicates the
safety of an extract to be used for antimalarial therapy
[37]. The index was calculated based on the ratio of
cytotoxicity (IC50) on HepG2 and MCF-7 cells to APM
activity (EC50). The SI was calculated for the most
potent extracts against K1 strain of P. falciparum with
EC50 ≤1.00 μg / m l .T h e yw e r eD C M : M e O He x t r a c t s
of A. angustiloba (0.46 μg/ml) and C. gigantea
(0.97 μg/ml), and HEX and DCM extracts of V. glabra
(1.00 and 0.85 μg/ml), respectively (Table 2). Against
HepG2 cells, IC50 values were all >25.0 μg/ml, and
against MCF-7 cells, IC50 values were >25.0, 16.8, >25.0
and 12.0 μg/ml, respectively.
Against HepG2 cells, HEX and DCM extracts of V.
glabra, and DCM:MeOH extracts of A. angustiloba and
C. gigantea were non-cytotoxic with SI values >25.0
(Table 2). Against MCF-7 cells, the DCM extract of V.
glabra and the DCM:MeOH extract of C. gigantea had
SI values of 14.1 and 17.3, respectively. The HEX extract
of V. glabra and the DCM:MeOH extract of A. angusti-
loba were non-cytotoxic with SI values >25.0.
Recently, a study on the antimalarial and cytotoxic activ-
ity of plants in the Democratic Republic of Congo consid-
ered SI values of extracts >10 as high [38]. With SI values
relatively higher than 10, the extracts of A. angustiloba,
Table 2 Antiplasmodial (APM) activity and selectivity index (SI) of leaf extracts of Apocynaceae species
Species
cLeaf extract
aEC50 (μg/ml) of APM activity
bIC50 (μg/ml) of APF activity
bSI of APM activity
K1 3D7 HepG2 MCF-7 HepG2 MCF-7
Alstonia angustiloba HEX 7.81 -
DCM - -
DCM:MeOH 0.46 - >25.0 >25.0 NC NC
MeOH 6.46 -
Calotropis gigantea HEX 5.82 -
DCM - -
DCM:MeOH 0.97 3.29 >25.0 16.8 NC 17.3
MeOH - -
Dyera costulata HEX - -
DCM - 8.31
DCM:MeOH 7.52 2.13
MeOH 7.74 3.56
Kopsia fruticosa HEX - -
DCM - 7.14
DCM:MeOH 4.35 -
MeOH 1.01 -
Vallaris glabra HEX 1.00 - >25.0 >25.0 NC NC
DCM 0.85 - >25.0 12.0 NC 14.1
DCM:MeOH 8.45 -
MeOH 8.42 -
dStandard drug
Artemisinin 0.001 0.001
Mefloquine 0.008 0.018
a EC50 or effective concentration (μg/ml) is the extract concentration that kills 50% of malaria parasites. Activity is not effective (-) if EC50 value >10 μg/ml. K1 and
3D7 are chloroquine-resistant and chloroquine-sensitive strains of Plasmodium falciparum, respectively.
b IC50 of antiproliferative (APF) activity and SI of APM activity against HepG2 and MCF-7 cells were calculated only for the most potent extracts against K1 strain
with EC50 ≤1.00 μg/ml. NC, non-cytotoxic with SI values >25.0.
c HEX, hexane; MeOH, methanol; DCM, dichloromethane.
d Standard drugs of artemisinin and mefloquine are used as positive controls.
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treat malaria.
Analysis of TAC, TPC and RSA
Of the five species analysed, MeOH crude and DCM
extracts of K. fruticosa had the highest TAC (100 and
129 mg BE/g of extract), respectively (Table 3). Other
species with high TAC were D. costulata and A. angusti-
loba with MeOH crude and DCM:MeOH extracts hav-
ing values in the range 58-68 and 23-58 mg BE/g of
extract, respectively. Based on TAC, the ranking of spe-
cies was: K. fruticosa >D. costulata >A. angustiloba >C.
gigantea ≈ V. glabra. Extracts of D. costulata had the
highest TPC and strongest RSA. MeOH crude, DCM:
MeOH and MeOH extracts yielded TPC values of 319,
354 and 279 mg GAE/g of extract, and RSA values of
377, 349 and 278 mg AA/g of extract, respectively.
Based on TPC and RSA, the ranking of species was: D.
costulata >V. glabra >K. fruticosa >A. angustiloba >C.
gigantea. There is a strong correlation between TPC
and RSA of extracts (R
2 =0 . 9 5 5 )b u tn o tw i t hT A C
(R
2 = 0.112). Correlation of results of phytochemical
analysis with APF and APM activities remains unclear.
Extracts of C. gigantea and V. glabra showed strong
APF activity. The former had low TAC and TPC, while
the latter had low TAC but high TPC. Extracts of
V. glabra and D. costulata were effective against K1 and
3D7 strains of P. falciparum, respectively. The former
had low TAC but high TPC, while the latter had high
TAC and TPC.
Phytochemical screening
Phytochemical screening showed the presence of terpe-
noids in all leaf extracts of V. glabra except MeOH
extract while saponins and tannins were present in
DCM and DCM:MeOH extracts, and in DCM:MeOH
and MeOH extracts, respectively (Table 4). Cardenolides
were not detected.
Terpenoids are used for the treatment of human dis-
eases such as cancer and malaria, and infectious diseases
caused by virus and bacterial [39]. Taxol and artimesinin
are renowned terpenoid-based anticancer and antimalar-
ial drugs, respectively. Terpenoids inhibit the growth or
induce apoptosis of breast cancer cells such as MCF-7,
MDA-MB-231 and T47D [40]. They are among the
most important natural antimalarial drugs, which also
include quinones and alkaloids [41].
Tannins are water-soluble polyphenols that are present in
many plant foods [42]. Literature on the effects of tannins
on human health is vast and sometimes conflicting. Inci-
dences of esophageal cancer have been attributed to con-
sumption of tannin-rich foods such as herbal teas,
suggesting that tannins might be carcinogenic. However,
reports have indicated a negative association between con-
sumption of tea and the incidence of cancer. Teas with high
tannin content have been suggested to be anticarcinogenic
Table 3 Phytochemical analysis of total alkaloid content, total phenolic content and radical-scavenging activity of leaf
extracts of Apocynaceae species
Species MeOH crude extract
aSequential extract
HEX DCM DCM:MeOH MeOH
bTotal alkaloid content (mg BE/g)
Kopsia fruticosa 100 ± 4.2 63 ± 1.1 129 ± 4.0 99 ± 2.5 46 ± 1.6
Dyera costulata 58 ± 2.5 2.4 ± 0.6 11 ± 1.8 68 ± 2.7 41 ± 2.4
Alstonia angustiloba 23 ± 0.3 13 ± 2.3 27 ± 3.1 58 ± 1.2 27 ± 1.0
Calotropis gigantea 2.7 ± 0.3 3.7 ± 1.0 8.6 ± 1.2 9.6 ± 1.9 9.2 ± 2.7
Vallaris glabra 2.7 ± 0.4 4.4 ± 0.8 8.9 ± 0.6 9.2 ± 0.2 8.7 ± 2.2
bTotal phenolic content (mg GAE/g)
Dyera costulata 319 ± 5.5 21 ± 0.2 23 ± 0.1 354 ± 6.0 279 ± 3.0
Vallaris glabra 99 ± 3.8 15 ± 0.9 24 ± 0.5 134 ± 1.0 164 ± 13
Kopsia fruticosa 83 ± 1.1 39 ± 0.5 20 ± 0.5 129 ± 1.0 84 ± 1.0
Alstonia angustiloba 68 ± 2.0 17 ± 0.6 24 ± 0.6 96 ± 1.1 94 ± 1.1
Calotropis gigantea 28 ± 0.8 14 ± 0.6 44 ± 1.7 42 ± 0.8 33 ± 0.5
bRadical-scavenging activity (mg AA/g)
Dyera costulata 377 ± 25 15 ± 0.3 9.3 ± 0.5 349 ± 21 278 ± 5.4
Vallaris glabra 84 ± 0.5 6.0 ± 0.3 8.4 ± 0.4 77 ± 2.2 119 ± 6.8
Kopsia fruticosa 63 ± 3.2 12 ± 1.4 7.5 ± 0.3 70 ± 2.0 48 ± 1.5
Alstonia angustiloba 29 ± 0.9 10 ± 0.2 5.7 ± 0.7 50 ± 1.2 46 ± 2.2
Calotropis gigantea 7.6 ± 0.4 5.6 ± 0.3 6.1 ± 0.4 8.0 ± 0.6 14 ± 1.3
a HEX, hexane; DCM, dichloromethane; MeOH, methanol.
b BE, boldine equivalent; GAE, gallic acid equivalent; AA, ascorbic acid. Values are in milligram per gram of extract.
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tive property in protecting cellular oxidative damage against
lipid peroxidaton and superoxide radicals. The antimicro-
bial activities of tannins are well documented.
Saponins are naturally occurring glycosides with a dis-
tinctive foaming characteristic and bitter taste [43,44].
They have a wide range of properties, which include
both beneficial and detrimental effects on human health.
Saponins affect the immune system in ways that help to
protect the human body against cancers, and also lower
cholesterol levels. They decrease blood lipids, lower can-
cer risks and lower blood glucose response.
Conclusions
The DCM extract of C. gigantea,a n dD C Ma n dD C M :
MeOH extracts of V. glabra inhibited the growth of all
six human cancer cell lines. Against MCF-7 and MDA-
MB-231 human cell lines, DCM leaf extract of C. gigan-
tea had stronger APF activity than standard drugs of
xanthorrhizol, curcumin and tamoxifen. With wide
spectrum APF activity, leaves of these two species are
therefore promising candidates as alternative resources
for anticancer drugs. Against K1 strain of P. falciparum,
all four extracts of V. glabra displayed effective APM
activity. Selectivity index values suggested that extracts
of V. glabra are potentially safe for use to treat malaria.
The wide spectrum APF and APM activities of V. glabra
are reported for the first time. This warrants further
investigation into its bioactive compounds.
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